Ahead of ADA 2021, Dr. Thomas Wadden discusses the significance of the Wegovy approval for chronic weight management and Novo Nordisk's plans to evaluate an oral version.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
